Skip To Content

Study ID: SH MISP203 Study- Powell and Merck Head and Neck

Title:

Phase IB study of Pembrolizumab in combination with chemo radiotherapy (CRT) for locally-advanced squamous cell carcinoma of the head and neck (SCCHN)

Location:
Bismarck Region, Fargo Region, Sanford Health, Sioux Falls Region
Principal Investigator:
Steven Powell, MD,Mark Gitau, MD,John Reynolds, MD
Disease:
Head & Neck
Stage:
Phase I
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.